A pancreatic cancer drug more than four decades in the making has cracked one of the most stubbornly lethal cancers, extending people’s lives and keeping their tumors in check for twice as long as ...

A new, experimental medication nearly doubled overall survival rates for patients with advanced pancreatic cancer, according to the results of a study published Sunday. Researchers say the findings ...

A new drug for pancreatic cancer is showing promise in early testing. Daraxonrasib is a daily pill designed to block cancer signals linked to the RAS gene. It has now finished an early-stage clinical ...

CHICAGO, May 31 (Reuters) - Revolution Medicine's (RVMD.O), opens new tab experimental pancreatic cancer pill doubled survival compared with chemotherapy and improved symptoms enough that some ...

A novel pill helped people with advanced pancreatic cancer live longer, researchers reported Sunday, raising hopes of long-needed better treatments for one of the deadliest types of cancer. “While not ...

An experimental pancreatic cancer drug has ignited hope in a field desperate for new treatments. Compared with traditional chemotherapy, a pill called daraxonrasib nearly doubled the survival time of ...

Experts hail daraxonrasib as ‘gamechanger’ for patients with advanced pancreatic cancer A daily pill can double survival time in patients with the world’s deadliest cancer, according to the results of ...

Dr. Ghanasyam Bey is from Cleveland, Ohio, and attended Princeton University for undergraduate studies. After a year of biology research at Duke University, he attended The Ohio State University ...

When news breaks, you need to understand what actually matters — and what to do about it. At Vox, our mission to help you make sense of the world has never been more vital. But we can’t do it on our ...

Exclusive: People from deprived and minority ethnic backgrounds have better access to device than for previous technologies The rollout of a “life-changing” artificial pancreas on the NHS for people ...

Every single patient with advanced pancreatic cancer who walked into Dr. Zev Wainberg’s office told him they would rather take an experimental medication than endure another round of chemotherapy.

A pill has been found to almost double the survival time for advanced pancreatic cancer patients, with experts describing the trial as a game changer. The drug, called daraxonrasib, appears to be a ...